However, their genomic profiling lacked diverse genetic alterations characterized in squamous cell carcinoma, such as SOX2 amplification in the squamous differentiation pathway; PIK3CA amplification in the PI3K signaling; and FGFR1 amplification in the RTK signaling pathway. The gene discussed is FGFR1; the disease is squamous cell carcinoma.